Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Integr Complement Med ; 29(1): 42-49, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36367978

ABSTRACT

Introduction: Multiple sclerosis (MS) is a progressive disease of the central nervous system that can result in highly variable effects on mobility and sensorimotor function. Persons with MS (pwMS) often use complementary and alternative approaches, such as acupuncture, to address these symptoms. However, studies of acupuncture on these symptoms have been hindered by methodologic flaws, which have limited the ability to draw conclusions about its efficacy. The purpose of this study was to examine the feasibility of an acupuncture intervention on a wide range of sensorimotor and mobility measurements in pwMS. Methods: Using a randomized crossover design, subjects experienced acupuncture or a no treatment control condition twice weekly for 4 weeks, followed by a 4-week washout period, and then crossed over to the other condition for 4 weeks. Strength, sensation, spasticity, gait, and balance were measured for all subjects, both before and after each condition. Results: Seven of the 12 subjects who started the program completed all phases. No subjects experienced adverse effects. No statistically significant changes were observed in the gait or balance measures. Small statistically significant changes were observed in upper extremity strength. Sensation and spasticity were unaffected. Discussion: The variability of MS suggests that a wide array of testing procedures be utilized, however, this may have led to difficulty with completing all phases of the study. Acupuncture did not result in changes in mobility in pwMS. Some improvements in upper extremity strength were observed. It is unclear whether these changes represent the effect of acupuncture or the inherent variability of MS.


Subject(s)
Acupuncture Therapy , Multiple Sclerosis , Humans , Acupuncture Therapy/adverse effects , Acupuncture Therapy/methods , Gait/physiology , Multiple Sclerosis/physiopathology , Multiple Sclerosis/therapy , Muscle Spasticity/physiopathology , Muscle Spasticity/therapy , Pilot Projects , Treatment Outcome , Feasibility Studies , Muscle Strength/physiology , Sensation/physiology , Postural Balance/physiology , Cross-Over Studies
2.
J Obstet Gynaecol Can ; 40(1): 68-71, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28822629

ABSTRACT

BACKGROUND: Pubic symphysis rupture significant enough to cause serious complications or require surgical intervention is exceedingly rare. Here we review the literature and examine the details of a unique presentation. CASE: A 27-year-old woman presented in labour at 34+6 weeks gestation after an uncomplicated monochorionic-diamniotic twin pregnancy. After vaginal delivery, she developed a substantial labial hematoma. Hours later, she became hemodynamically unstable. Imaging revealed a 4.7-cm pubic diastasis and a small arterial tear. One week later, the diastasis had expanded to 6 cm on X-ray. As a result, the patient underwent surgical intervention. She was discharged home on postpartum day 21 and remained non-weight-bearing for 8 weeks. CONCLUSION: Pubic symphysis rupture is a potentially life-threatening obstetrical complication that requires early recognition and effective multidisciplinary care.


Subject(s)
Arteries/injuries , Obstetric Labor Complications/surgery , Pubic Symphysis/injuries , Vascular System Injuries/etiology , Adult , Female , Humans , Pregnancy , Pregnancy, Twin , Pubic Symphysis/surgery , Resuscitation
3.
Eur J Hum Genet ; 24(7): 968-75, 2016 07.
Article in English | MEDLINE | ID: mdl-26577044

ABSTRACT

Non-invasive prenatal testing is increasingly available worldwide and stakeholder viewpoints are essential to guide implementation. Here we compare the preferences of women and health professionals from nine different countries towards attributes of non-invasive and invasive prenatal tests for Down syndrome. A discrete choice experiment was used to obtain participants' stated preference for prenatal tests that varied according to four attributes: accuracy, time of test, risk of miscarriage, and type of information. Pregnant women and health professionals were recruited from Canada, Denmark, Iceland, Israel, Italy, the Netherlands, Portugal, Singapore, and the United Kingdom. A total of 2666 women's and 1245 health professionals' questionnaires were included in the analysis. Differences in preferences were seen between women and health professionals within and between countries. Overall, women placed greater emphasis on test safety and comprehensive information than health professionals, who emphasised accuracy and early testing. Differences between women's and health professionals' preferences are marked between countries. Varied approaches to implementation and service delivery are therefore needed and individual countries should develop guidelines appropriate for their own social and screening contexts.


Subject(s)
Down Syndrome/diagnosis , Health Knowledge, Attitudes, Practice , Health Personnel/psychology , Pregnant Women/psychology , Prenatal Diagnosis/psychology , Canada , Down Syndrome/genetics , European Union , Female , Genetic Testing/ethics , Humans , Israel , Male , Pregnancy , Singapore
4.
Am J Obstet Gynecol ; 202(3): 239.e1-239.e10, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20207239

ABSTRACT

OBJECTIVE: We sought to investigate whether prenatal vitamin C and E supplementation reduces the incidence of gestational hypertension (GH) and its adverse conditions among high- and low-risk women. STUDY DESIGN: In a multicenter randomized controlled trial, women were stratified by the risk status and assigned to daily treatment (1 g vitamin C and 400 IU vitamin E) or placebo. The primary outcome was GH and its adverse conditions. RESULTS: Of the 2647 women randomized, 2363 were included in the analysis. There was no difference in the risk of GH and its adverse conditions between groups (relative risk, 0.99; 95% confidence interval, 0.78-1.26). However, vitamins C and E increased the risk of fetal loss or perinatal death (nonprespecified) as well as preterm prelabor rupture of membranes. CONCLUSION: Vitamin C and E supplementation did not reduce the rate of preeclampsia or GH, but increased the risk of fetal loss or perinatal death and preterm prelabor rupture of membranes.


Subject(s)
Antioxidants/therapeutic use , Ascorbic Acid/therapeutic use , Dietary Supplements , Pre-Eclampsia/prevention & control , Vitamin E/therapeutic use , Adult , Double-Blind Method , Female , Fetal Death/epidemiology , Fetal Membranes, Premature Rupture/epidemiology , Humans , Hypertension, Pregnancy-Induced/epidemiology , Hypertension, Pregnancy-Induced/prevention & control , Pre-Eclampsia/epidemiology , Pregnancy , Prenatal Care , Risk , Risk Factors
5.
Am J Obstet Gynecol ; 199(6): 620.e1-8, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18973872

ABSTRACT

OBJECTIVE: We conducted a metaanalysis to determine whether antibiotics prolong pregnancy and reduce neonatal morbidity in preterm premature rupture of membranes (PPROM) and preterm labor (PTL) at 34 weeks or less. STUDY DESIGN: Randomized trials comparing antibiotic therapy with placebo in PPROM or PTL at a gestation of 34 weeks or less were retrieved. The primary outcome was time to delivery (latency). Infant outcomes included mortality, infection, neurological abnormality, respiratory disease, and neonatal stay. RESULTS: Antibiotics were associated with prolongation of pregnancy in PPROM (P < .01) but not PTL. Clinically diagnosed neonatal infections were reduced in both groups; there was a trend toward reduced culture-positive sepsis in PPROM. Intraventricular hemorrhage (all grades) was reduced in PPROM. Other neonatal outcomes were unaffected by antenatal antibiotics. CONCLUSION: Antibiotics prolong pregnancy and reduce neonatal morbidity in women with PPROM at a gestation of 34 weeks or less. In PTL at a gestation of 34 weeks or less, there is little evidence of benefit from administration of antibiotics.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Fetal Membranes, Premature Rupture/drug therapy , Infant, Premature, Diseases/prevention & control , Obstetric Labor, Premature/drug therapy , Pregnancy Outcome , Adult , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Fetal Membranes, Premature Rupture/prevention & control , Follow-Up Studies , Humans , Infant Mortality/trends , Infant, Newborn , Infant, Premature , Obstetric Labor, Premature/prevention & control , Pregnancy , Pregnancy Trimester, Third , Probability , Randomized Controlled Trials as Topic , Reference Values , Treatment Outcome , Young Adult
6.
Am J Obstet Gynecol ; 191(4): 1486-90, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15507988

ABSTRACT

OBJECTIVE: The purpose of this study was to examine prospectively the association between increased nuchal translucency thickness and major cardiac defects in chromosomally normal fetuses. STUDY DESIGN: A prospective cohort study of 263 chromosomally normal fetuses with an increased nuchal translucency thickness at 11 to 14 weeks of gestation at a tertiary referral center was performed. The incidence of major cardiac defects was examined in relation to the fetal nuchal translucency thickness at the 11 to 14 week ultrasound examination. RESULTS: The nuchal translucency thickness measurements ranged from 2.2 to 8.0 mm (median, 3.1 mm). There were 13 cases of major cardiac defects in this cohort, which gave a prevalence of 49.4 of every 1000 fetuses. With the use of the 99th percentile of nuchal translucency thickness, the prevalence rose to 106.7 of every 1000 fetuses. CONCLUSION: In this population of chromosomally normal fetuses with an increased nuchal translucency thickness, the incidence of cardiac defects was high, which suggests that fetal echocardiography is indicated in this group.


Subject(s)
Fetal Diseases/diagnostic imaging , Heart Defects, Congenital/diagnostic imaging , Nuchal Translucency Measurement , Ultrasonography, Prenatal , Adult , Female , Heart Defects, Congenital/physiopathology , Humans , Pregnancy , Pregnancy Trimester, First , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL